These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3265717)

  • 1. Disease patterns in experimental allergic neuritis (EAN) in the Lewis rat. Is EAN a good model for the Guillain-Barré syndrome?
    Brosnan JV; King RH; Thomas PK; Craggs RI
    J Neurol Sci; 1988 Dec; 88(1-3):261-76. PubMed ID: 3265717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Neuroscience; 2008 Mar; 152(2):495-501. PubMed ID: 18276080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
    Jung S; Toyka K; Hartung HP
    Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A.
    McCombe PA; van der Kreek SA; Pender MP
    Neuropathol Appl Neurobiol; 1992 Apr; 18(2):171-87. PubMed ID: 1620277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats.
    Izumo S; Linington C; Wekerle H; Meyermann R
    Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic relapsing experimental allergic neuritis in Lewis rats: effects of thymectomy and splenectomy.
    Craggs RI; Brosnan JV; King RH; Thomas PK
    Acta Neuropathol; 1986; 70(1):22-9. PubMed ID: 3487906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Enders U; Toyka KV; Hartung HP; Gold R
    J Neuroimmunol; 1997 Jun; 76(1-2):112-6. PubMed ID: 9184640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis.
    Deng YN; Zhou WB
    Neuroimmunomodulation; 2007; 14(6):337-43. PubMed ID: 18434754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.
    Vriesendorp FJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S164-8. PubMed ID: 9396704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced Exercise Preconditioning Attenuates Experimental Autoimmune Neuritis by Altering Th1 Lymphocyte Composition and Egress.
    Calik MW; Shankarappa SA; Langert KA; Stubbs EB
    ASN Neuro; 2015; 7(4):. PubMed ID: 26186926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental allergic neuritis in the Lewis rat.
    Smith ME; Forno LS; Hofmann WW
    J Neuropathol Exp Neurol; 1979 Jul; 38(4):377-91. PubMed ID: 312920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens.
    Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J
    J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN.
    Wang YZ; Liang QH; Ramkalawan H; Zhang W; Zhou WB; Xiao B; Tian FF; Yang H; Li J; Zhang Y; Xu NA
    Immunol Invest; 2012; 41(2):171-82. PubMed ID: 21864114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.